European Biotechnology Spring 2022 Leseprobe

ISSN  2364-2351 | A  60711 |

Life Sciences and Industry Magazine Spring Edition 2022 | Volume  21 | 20 €

Interview Cellino Biotech CEO Nabiha Saklayen on making cell-based therapies 10x cheaper.

Climate catastrophe

FREE EXCERPT

Saving the planet with biotechnology

Agri-biotech

Capital Markets

COVID-19

Bioprocessing

How deregulating gene editing impacts the organic market

Riding the funding wave in Europe in the pandemic era

How T cells ameliorate the immune response to vaccines

Drugmakers and CDMOs see huge growth in new biologicals